Efficacy and safety of endoscopic ultrasound-guided ethanol ablation therapy for pancreatic neuroendocrine tumors

Kazuyuki Matsumoto, Hironari Kato, Koichiro Tsutsumi, Sho Mizukawa, Syuntaro Yabe, Hiroyuki Seki, Yutaka Akimoto, Daisuke Uchida, Takeshi Tomoda, Naoki Yamamoto, Shigeru Horiguchi, Hiroyuki Okada

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Recently, endoscopic ultrasonography (EUS)-guided ethanol ablation for small pancreatic neuroendocrine tumors (p-NETs) has been reported. However, the efficacy and safety of the technique remain unclear. We have launched a prospective pilot study of EUS-guided ethanol ablation for p-NETs. The major eligibility criteria are the presence of a pathologically diagnosed grade (G) 1 or G2 p-NET, a tumor size of ≤2cm, and being a poor candidate for surgery. A total of 5 patients will be treated. The primary endpoint will be the complete ablation rate at 1 month after treatment.

Original languageEnglish
Pages (from-to)313-316
Number of pages4
JournalActa medica Okayama
Volume70
Issue number4
Publication statusPublished - 2016

Keywords

  • EUS-guided
  • Ethanol ablation
  • Pancreatic neuroendocrine tumor

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Efficacy and safety of endoscopic ultrasound-guided ethanol ablation therapy for pancreatic neuroendocrine tumors'. Together they form a unique fingerprint.

  • Cite this